Header Logo

Connection

Gabriel Pardo to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Gabriel Pardo has written about Dose-Response Relationship, Drug.
Gabriel Pardo
Connection Strength
0.016
Dose-Response Relationship, Drug
  1. Immunogenicity and tolerability of an investigational formulation of interferon-beta1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis. Clin Ther. 2007 Jun; 29(6):1128-45.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.